Cybin (HELP) Other Working Capital Changes (2024)
Cybin's (HELP) quarterly Other Working Capital Changes came in at -$7.4 million in Q1 2026, down 59281.33% YoY from N/an in Q1 2025, and down 3093.55% on a QoQ basis from $248000.0 in Q4 2025.
Cybin (HELP) Other Working Capital Changes (2024) Analysis & Trends
Cybin (HELP) has 1 years of Other Working Capital Changes data on file, last reported at -$81606.8 in Q4 2024.
- Quarterly Other Working Capital Changes fell 59281.33% year-over-year to -$7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.8 million (down 1225.55% YoY) and the FY2026 annual result came in at -$6.8 million, up 48.61% from the prior year.
- Other Working Capital Changes fell to -$7.4 million in Q1 2026, from $248000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $630731.6 in Q1 2023 to a low of -$7.4 million in Q1 2026.
- A 5-year average of -$421458.2 and a median of $12544.5 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes surged 962.08% — and 2026, when it slumped 59281.33%.
- Tracing HELP's Other Working Capital Changes over 5 years: stood at $67040.0 in 2022, then tumbled by 404.6% to -$204200.9 in 2023, then plunged by 363.44% to -$946352.6 in 2024, then surged by 126.21% to $248000.0 in 2025, then plunged by 3093.55% to -$7.4 million in 2026.
- The last three Other Working Capital Changes figures came in at -$81606.8 (Q4 2024), -$65974.8 (Q3 2024), and -$62878.1 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cybin | 417.29 Mn | 417.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -81,606.80 |
| Dec 31, 2024 | -81,606.80 |
| Dec 31, 2024 | -81,606.80 |
| Sep 30, 2024 | -65,974.81 |
| Sep 30, 2024 | -65,974.81 |
| Sep 30, 2024 | -65,974.81 |
| Jun 30, 2024 | -62,878.09 |
| Jun 30, 2024 | -62,878.09 |
| Jun 30, 2024 | -62,878.09 |